Femtogenix to present a plenary session entitled “Pyridinobenzodiazepines: A Novel Class of ADC Payloads” at World ADC San Diego 2017

Professor David Thurston, Chief Scientific Officer of Femtogenix Ltd will present data on a new class of ADC payload developed by the company. The pyridinobenzodiazepines are a sequence-specific, DNA mono-alkylating class of payload. The presentation will illustrate a payload mechanism of action new to the ADC field, potent in vitro and in vivo activity, ease of conjugation and enhanced therapeutic window relative to currently available payload classes.

Further information can be found here: http://worldadc-usa.com/